GSK Study Shows Tykerb/Herceptin Combo Increases Progression-Free Survival In Breast Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm unveils positive Phase III data in women with HER-2 positive metastatic breast cancer weeks ahead of ASCO annual meeting.